Singapore markets closed

Axsome Therapeutics, Inc. (AXSM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
76.54-0.81 (-1.05%)
At close: 04:00PM EDT
77.95 +1.41 (+1.84%)
Pre-market: 08:03AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-296,377
-239,238
-187,134
-130,403
-102,901
Depreciation & amortisation
7,003
6,834
4,402
76
77.718
Stock-based compensation
69,867
62,620
37,726
20,803
14,756
Change in working capital
-25,572
-28,392
23,670
324
412.041
Accounts receivable
-56,642
-57,121
-37,699
0
0
Inventory
-1,013
-4,462
-5,275
-6
-177.5
Accounts payable
18,021
2,074
25,456
-355
2,561
Other working capital
-193,335
-145,662
-117,213
-108,534
-78,502
Other non-cash items
52,353
53,096
4,825
974
7,951
Net cash provided by operating activities
-192,726
-145,080
-116,511
-108,226
-78,457
Cash flows from investing activities
Investments in property, plant and equipment
-609
-582
-702
-308
-45.891
Acquisitions, net
-
0
-53,000
0
0
Net cash used for investing activities
-609
-582
-53,702
-308
-45.891
Cash flows from financing activities
Debt repayment
-
-
0
0
-21,660
Common stock issued
-
258,750
243,763
7,436
14,126
Other financing activities
-24,859
-25,156
-10,432
-708
-1,103
Net cash used provided by (used for) financing activities
278,261
331,013
284,582
11,130
42,413
Net change in cash
84,926
185,351
114,369
-97,404
-36,090
Cash at beginning of period
246,515
200,842
86,473
183,877
219,966
Cash at end of period
331,441
386,193
200,842
86,473
183,876
Free cash flow
Operating cash flow
-192,726
-145,080
-116,511
-108,226
-78,457
Capital expenditure
-609
-582
-702
-308
-45.891
Free cash flow
-193,335
-145,662
-117,213
-108,534
-78,502